东亚药业最新股东户数环比下降5.64%

Summary of Key Points Core Viewpoint - Dongya Pharmaceutical reported a decrease in the number of shareholders and a significant decline in revenue and net profit for the first quarter of the year [2] Shareholder Information - As of July 20, the number of shareholders for Dongya Pharmaceutical was 11,203, a decrease of 670 from the previous period (July 10), representing a decline of 5.64% [2] Stock Performance - The closing price of Dongya Pharmaceutical was 20.79 yuan, an increase of 0.92%, with a cumulative increase of 8.22% since the concentration of shares began. The stock experienced 9 days of increases and 4 days of decreases during this period [2] Financial Performance - In the first quarter, Dongya Pharmaceutical achieved a revenue of 191 million yuan, a year-on-year decrease of 45.85%. The net profit was -6.92 million yuan, a year-on-year decline of 128.78%, with a basic earnings per share of -0.0600 yuan [2] - On July 15, the company released a performance forecast for the first half of the year, expecting a net profit loss between -35 million yuan and -28 million yuan [2]